Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1781
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG.NO:BG0121017-
dc.date.accessioned2025-04-26T09:39:16Z-
dc.date.available2025-04-26T09:39:16Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1781-
dc.description.abstractABSTRACT Introduction: Ventilator-associated pneumonia (VAP) is a severe nosocomial infection in ICU settings, especially when caused by multidrug-resistant Acinetobacter baumannii. This study aimed to evaluate the clinical profile, risk factors, resistance patterns, and prognostic indicators in patients with VAP due to A. baumannii. Materials and Methods: A one-year cross-sectional study (January 2023 – December 2023) was conducted at KLE’s Dr. Prabhakar Kore Hospital. 68 patients with culture-confirmed VAP were included. Data on demographics, clinical characteristics, and resistance patterns were collected. Prognostic scores, including Glasgow Coma Scale (GCS), APACHE II, Q-SOFA, and SAPS II, were analyzed for mortality prediction.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.titleClinical profile, risk factors and Resistancepattern of patients with ventilator Associated pneumonia due to acinetobacter Baumannii in intensive care units - a one-year Cross-sectional study in kle’s dr. Prabhakar Kore hospital and medical research centre, Belagavien_US
dc.typeDissertationsen_US
Appears in Collections:General Medicine MD

Files in This Item:
File Description SizeFormat 
BG0121017.pdf3.97 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.